Your browser doesn't support javascript.
loading
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
Natalicchio, A; Montagnani, M; Gallo, M; Marrano, N; Faggiano, A; Zatelli, M C; Mazzilli, R; Argentiero, A; Danesi, R; D'Oronzo, S; Fogli, S; Giuffrida, D; Gori, S; Ragni, A; Renzelli, V; Russo, A; Franchina, T; Tuveri, E; Sciacca, L; Monami, M; Cirino, G; Di Cianni, G; Colao, A; Avogaro, A; Cinieri, S; Silvestris, N; Giorgino, F.
Afiliación
  • Natalicchio A; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Montagnani M; Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, Medical School, University of Bari Aldo Moro, Bari, Italy.
  • Gallo M; Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy.
  • Marrano N; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy.
  • Faggiano A; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
  • Zatelli MC; Section of Endocrinology, Geriatrics, and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Mazzilli R; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
  • Argentiero A; Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • D'Oronzo S; Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.
  • Fogli S; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Giuffrida D; Department of Oncology, Istituto Oncologico del Mediterraneo, Viagrande, Catania, Italy.
  • Gori S; Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, Verona, Italy.
  • Ragni A; Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy.
  • Renzelli V; Diabetologist and Endocrinologist, Italian Association of Clinical Diabetologists, Rome, Italy.
  • Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Franchina T; Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.
  • Tuveri E; Diabetology, Endocrinology and Metabolic Diseases Service, ASL-Sulcis, Carbonia, Sardinia, Italy.
  • Sciacca L; Department of Clinical and Experimental Medicine, Endocrinology Section, University of Catania, Catania, Italy.
  • Monami M; Diabetology, Careggi Hospital and University of Florence, Firenze, Italy.
  • Cirino G; Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Di Cianni G; Diabetes Unit, Livorno Hospital, Livorno, Italy.
  • Colao A; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy; UNESCO Chair, Education for Health and Sustainable Development, Federico II University, Naples, Italy.
  • Avogaro A; Department of Medicine, University of Padova, Padua, Italy.
  • Cinieri S; Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy.
  • Silvestris N; Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.
  • Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. Electronic address: francesco.giorgino@uniba.it.
ESMO Open ; 8(3): 101573, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37263082
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: MicroARNs / Diabetes Mellitus Tipo 2 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: MicroARNs / Diabetes Mellitus Tipo 2 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article País de afiliación: Italia